Rheumatologic Disorders

Disease State Hub

Research Summaries

Rheumatologic disorders

Study Examines Effectiveness of Biosimilar for Inflammatory Arthritis

05/15/2017

A recent study examined the impact of a nation-wide, non-medical switch from originator to biosimilar on disease activity and retention rates among patients with rheumatoid arthritis, psoriatic arthritis,...

05/15/2017

Research Summaries

Conference Coverage

Updates in the Treatment, Management of Osteoporosis and Osteopenia

07/24/2024

Robert Wermers, MD, and Monica Richey, MSN, ANP-bc, provide management updates and guidelines for clinicians who are treating patients with osteoporosis and osteopenia in their session at the Practical...

07/24/2024

Research Summary

Global Disease Burden of Osteoarthritis Across Two Decades and Future Projections

01/10/2024

Jessica Ganga

Osteoarthritis is a common chronic and degenerative disease among adults. A group of experts estimated the disease’s burden spanning two decades and the projection of burden to 2050.

01/10/2024

FDA ALERT

FDA Approves First Biosimilar to Tocilizumab to Treat Adults, Pediatric Patients With Arthritis

11/15/2023

Jessica Ganga

In late September, the FDA approved the first biosimilar to tocilizumab to treat adult and pediatric patients with various indications of arthritis.

11/15/2023

research summary

research summary

Drug Survival, Effectiveness of IL-23 Inhibitors for Psoriasis, PsA

10/26/2023

Leigh Precopio

Despite being approved for use, consensus among the real-world data on the use of IL-23 inhibitors in psoriatic disease has been lacking; therefore, researchers recently examined the drug survival and...

10/26/2023

research summary

research summary

Efficacy, Safety of Risankizumab for Treatment of Active Psoriatic Arthritis

06/21/2023

Leigh Precopio

Researchers examined the efficacy and safety of a humanized monoclonal antibody for the treatment of active psoriatic arthritis in some patient populations.

06/21/2023

August 2024

Current Issue

August 2024